• FirefoxUpgrade to the new Firefox »
  •  Dow Down 0.79% Nasdaq Up 0.16%

    Merrimack Pharmaceuticals, Inc. (MACK)

    -NasdaqGM
    9.59 Down 0.23(2.34%) Jan 23, 4:00PM EST
    |After Hours : 9.59 0.00 (0.00%) Jan 23, 4:31PM EST
    Add to Portfolio
    Prev Close:9.82
    Open:9.72
    Bid:N/A
    Ask:12.15 x 100
    1y Target Est:13.83
    Beta:1.04
    Earnings Date:Feb 25 - Mar 2 (Est.)
    Day's Range:9.50 - 9.81
    52wk Range:4.13 - 12.00
    Volume:1,448,337
    Avg Vol (3m):1,963,330
    Market Cap:1.02B
    P/E (ttm):N/A
    EPS (ttm):-1.03
    Div & Yield:N/A (N/A)
    Quotes delayed, except where indicated otherwise. Currency in USD.

    Headlines

    » More Headlines for MACK

    Comparison

    Symbol% ChgMkt Cap
    MACKDown 2.34%1.02B
    IMMUDown 1.66%440.52M
    LRUSF 0.00%N/A
    THLD 0.00%220.88M

    Key Statistics

    Forward P/E (1 yr):N/A
    P/S (ttm):13.56
    Ex-Dividend Date:N/A

    Analysts

    Annual EPS Est (Dec-14) :-0.88
    Quarterly EPS Est (Dec-14) :-0.19
    Mean Recommendation*:1.6
    PEG Ratio (5 yr expected):-1.95

    * (Strong Buy) 1.0 - 5.0 (Sell)

    Analyst Opinion | Estimates

    Business Summary

    Merrimack Pharmaceuticals, Inc., a biopharmaceutical company, is engaged in discovering, developing, and preparing to commercialize medicines paired with companion diagnostics for the treatment of cancer primarily in the United States. View More
    Your browser doesn't support canvas
    SETTINGS
    Scrolling
    Speed
    Display
    Price
    Submit Feedback